Building Clinical Supply Agility in a Changing Trial Landscape

Building Clinical Supply Agility in a Changing Trial Landscape

Jul 16, 2025PAO-07-25-CL-02

As clinical trials grow more complex and globally dispersed, small and mid-sized biotechnology and pharmaceutical companies increasingly require agile, hands-on partners to manage their clinical supply chains. Experic meets that need with white-glove clinical primary and secondary packaging, storage, and distribution services — backed by deep expertise, responsive communication, and flexible, end-to-end support.

Tailored Support for an Increasingly Complex Clinical Supply Landscape

The complexity of clinical material supply has grown exponentially in recent years as clinical trials become more global, more specialized, and more decentralized. The expansion in study types, geographies, and regulatory expectations has placed significant logistical pressure on sponsors — particularly small and emerging biotechnology and pharmaceutical companies that are now driving a larger share of early-stage innovation.

These companies often operate with lean internal teams and limited clinical logistics experience, making them heavily reliant on outsourcing partners. However, consolidation within the clinical supply sector has led many large providers to prioritize scale over service, adopting standardized, highly automated processes. While efficient for high-volume programs, this model often lacks the responsiveness and hands-on support that smaller companies need. Client interactions may be routed through online portals rather than live conversations with experienced experts who can resolve problems quickly and effectively.

What smaller innovators truly need is a partner capable of adapting to their unique program requirements — a partner that offers flexibility, technical expertise, and a sense of urgency. This means going beyond templated service offerings to deliver proactive communication, fast decision-making, and a personal commitment to each project's success.

A Purpose-Built Partner for Emerging Innovators

Experic was created with a clear mission: to support small and mid-sized companies with the kind of personalized, technically advanced outsourcing services they often struggle to find at larger providers. From the beginning, the company has combined state-of-the-art GMP clinical supply services with specialized manufacturing capabilities, including expertise in encapsulation, inhalation therapies, and high-potency drug handling.

Experic’s purpose-built facility in Cranbury, New Jersey was selected with growth in mind. Though initially larger than the company required, the site was strategically chosen to enable future expansion within a single, unified location. This deliberate decision stands in contrast to the fragmented footprints of many large contract development and manufacturing organizations (CDMOs), which operate across multiple sites and often require cross-facility material transfers that introduce added time, cost, and risk.

By maintaining all operations — manufacturing, packaging, storage, and distribution — under one roof, Experic ensures seamless integration, consistent quality management, and faster turnaround. The entire site operates under the same quality management system and with a single, highly experienced team, providing continuity and control that translates directly into value for clients. This centralized approach is a cornerstone of Experic’s flexible, customer-first philosophy, making it easier for sponsors to scale as they grow without sacrificing service or oversight.

Flexible Offerings, Integrated Value

Experic provides flexible support tailored to the needs of small and mid-sized drug developers — whether they require full end-to-end services or targeted support at a specific stage of development. Sponsors can engage Experic for process development, clinical manufacturing, primary and secondary packaging, labeling, and distribution as a comprehensive solution, or opt for standalone services such as clinical trial supply packaging or manufacturing alone.

While Experic excels at meeting sponsors wherever they are in their development journey, the greatest value is often unlocked when clients take advantage of the full service continuum. By centralizing drug product manufacturing, quality control testing, and clinical packaging and distribution within a single partner, sponsors eliminate the complexity and cost of coordinating multiple vendors. That means fewer audits, streamlined documentation, and faster time to clinic — all supported by a unified team operating under one quality management system.

This fully integrated approach is especially valuable for emerging companies managing lean teams and aggressive timelines, enabling them to stay focused on innovation while Experic handles the operational execution.

Speed Without Compromise

In today’s competitive pharmaceutical landscape, reaching the clinic quickly can determine a product’s commercial viability. As funders grow increasingly selective, sponsors developing first-in-class or highly differentiated therapies have a clear edge — while other drugs face an uphill battle. For small and emerging companies, delays in clinical material readiness can mean missed windows of opportunity and lost market potential.

Unfortunately, large outsourcing providers often struggle to offer the responsiveness these companies need. Multilayered hierarchies can make it difficult to escalate issues quickly, and decision-making is frequently slowed by internal bureaucracy.

Experic was designed differently. With a flat organizational structure and a hands-on leadership team, the company can respond to problems in real time. When an issue arises, clients don’t have to wait days to get an answer — they’re immediately connected to experts, including the head of quality and operations, who work collaboratively to diagnose the issue, implement a corrective action plan, and keep the project on track. This agility not only shortens turnaround times; it builds trust, ensuring clients feel supported at every stage, especially when the unexpected occurs.

Where Planning Meets Precision

At Experic, storage management is not an afterthought — it’s a strategic pillar designed to prevent problems before they occur. Each engagement begins with detailed planning discussions involving the client and their shipping partners to ensure that all product specifications are understood before materials ever reach the site. These details are proactively entered into Experic’s enterprise resource planning (ERP) system, which governs a guided “put-away” process. Warehouse technicians receive automated prompts to ensure every product is directed to the correct storage environment, and any attempted misplacement is flagged in real time.

This disciplined process is supported by robust infrastructure and multiple layers of built-in redundancy. Experic’s warehouse can accommodate a full range of temperature conditions—from controlled ambient (15–25 °C) to refrigerated (2–8 °C), frozen (–15 to –25 °C), and ultra-cold (–70 °C). Backup generators, compressors, and environmental controls ensure uninterrupted protection for even the most sensitive materials. The facility is also fully licensed and equipped to manage Schedule II through V substances and other highly regulated materials, with advanced security systems and redundancies safeguarding every square foot.

In addition to its current operational space, Experic has proactively invested in future capacity. A recently added 15,000-ft.2 of ambient and controlled-temperature storage includes overflow areas outfitted with a dedicated air handling system. That system is designed for modular relocation to the remaining 25,000 ft.2 of unused warehouse space on-site — enabling rapid expansion of controlled ambient storage to meet customer needs without disrupting ongoing operations. This forward-thinking design ensures that Experic can grow with its clients, scaling storage capacity in lockstep with their evolving clinical pipelines.

When Returns Become Urgent, Responsiveness Matters

Managing returns of expired or unused clinical materials is a critical but often underappreciated element of clinical trial logistics. Best practices require that expired products be promptly removed from trial sites, but return planning is frequently deprioritized until the issue becomes urgent. This delay can create logistical headaches, especially for materials requiring stringent temperature control or those classified as controlled substances, which often have limited on-site storage allowances.

Experic is uniquely positioned to address these time-sensitive challenges. Thanks to its flat organizational structure and experienced clinical supply team, the company can move swiftly to develop return protocols, secure inspection documentation, and coordinate shipment and disposition without delay. Whether handling ambient, refrigerated, frozen, or Schedule II–V substances, Experic ensures that clients maintain compliance while minimizing site disruptions.

While returns may not command headlines, they are a key part of the clinical supply chain — and one where Experic’s agility, regulatory expertise, and commitment to service excellence make a measurable difference.

A Direct Line into the European Union

As clinical trials continue to globalize, pharmaceutical companies increasingly require logistics partners that can seamlessly support cross-border storage, distribution, and regulatory compliance. To meet this demand, Experic is expanding its global footprint with a new storage and distribution facility in Ireland — strategically located near a major international airport and within a thriving pharmaceutical hub and equipped for secondary packaging.

This investment represents more than geographic expansion; it marks a shift from reliance on third-party vendors to full ownership of the clinical material supply chain in the European Union. By bringing these capabilities in-house, Experic enhances its control over logistics execution, improves service reliability, and strengthens quality oversight.

One of the most critical advantages of the Irish facility is direct access to Qualified Person (QP) services, a regulatory requirement in the EU for releasing investigational products to clinical sites. Previously, QP access through partners had posed occasional bottlenecks. By controlling this function internally, Experic ensures more consistent, uninterrupted delivery to European sites, reducing the risk of delays for its clients.

The new site is scheduled for inspection by the Health Products Regulatory Authority (HPRA) in Q3 2025, with operations expected to commence by late Q3 or Q4 2025. Demand is already building, with five to seven clients expressing interest in onboarding immediately upon regulatory approval. Designed with both warehouse capacity and secondary packaging capabilities, the Irish facility reinforces Experic’s end-to-end service model — now on a global scale.

Responsiveness That Builds Relationships

From its founding, Experic has been committed to serving customers with a level of responsiveness and care rarely found in today’s increasingly automated clinical supply landscape. Every aspect of the organization, from team structure to facility design, reflects this mission. The result is a highly agile partner that delivers tailored solutions, rapid execution, white-glove service, and unwavering support throughout the clinical trial journey.

Although Experic is a relatively young company, its team is anything but inexperienced. With decades of collective background in clinical trial supply, including deep GMP knowledge and an acute awareness of the pressures surrounding clinical timelines, Experic staff are uniquely equipped to navigate complexity and preempt challenges. The company hires selectively, prioritizing candidates with hands-on CTS experience to ensure that every client interaction is informed by real-world insight.

That experience translates into action. Clients routinely rely on Experic to step in when other vendors fall short — repackaging, relabeling, and shipping urgent clinical materials within 24 hours when needed. New programs can be onboarded in a week or less after all materials are received, thanks to available capacity, streamlined internal processes, and a leadership team that is always accessible.

Experic’s infrastructure is expanding in tandem with its reputation. Recent investments include a significant increase in U.S. storage capacity, new capabilities in spray drying and high-potency material handling, and the establishment of a European distribution and storage facility in Ireland. These developments not only enhance Experic’s service offering—they also reflect a forward-thinking strategy to support global clients at every stage of growth.

With an end-to-end clinical supply platform, exceptional responsiveness, and a commitment to long-term partnership, Experic has become a trusted extension of its clients’ teams. Many engagements have evolved into multi-project collaborations, grounded in shared success and mutual trust.